Manning Martha E
- SEC CIK
- 0001227894
No open-market purchases or sales filed in the past year.
Current role at each company
- MRNS Marinus Pharmaceuticals, Inc.SVP, GEN. COUNSEL & CORP. SEC.as of Feb 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Manning Martha E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 (view filing) | Aug 7-8 | 1 day | Manning Martha ESVP, GEN. COUNSEL & CORP. SEC. | SSale | −2.18K | $9.54 | −$20.8K | −6.2%33.0K after | 2 lots10b5-1 |
| Feb 22, 2024 (view filing) | Feb 20 | 2 days | Manning Martha ESVP, GEN. COUNSEL & CORP. SEC. | SSale | −1.89K | $9.57 | −$18.1K | −3.5%53.0K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Manning Martha ESVP, GEN. COUNSEL & CORP. SEC. | SSale | −3.62K | $1.13 | −$4.09K | −5.7%60.3K after |